MiR-1179 expression is markedly declined in oral cancer, and it can inhibit cell proliferation, enhance vincristine sensitivity and induce apoptosis by regulating MEK/ERK and PI3K/AKT signaling pathways [12]. Here, MAP2K7 is linked to lip and oral cavity carcinoma.